TY - JOUR
T1 - Hypothesis
T2 - Microtubule instability and paired helical filament formation in the alzheimer disease brain are related to apolipoprotein E genotype
AU - Strittmatter, Warren J.
AU - Weisgraber, Karl H.
AU - Goedert, Michel
AU - Saunders, Ann M.
AU - Huang, David
AU - Corder, Elizabeth H.
AU - Dong, Li Ming
AU - Jakes, Ross
AU - Alberts, Mark J.
AU - Gilbert, John R.
AU - Han, Seol Heui
AU - Hulette, Christine
AU - Einstein, Gillian
AU - Schmechel, Donald E.
AU - Pericak-Vance, Margaret A.
AU - Roses, Allen D.
PY - 1994/2
Y1 - 1994/2
N2 - A genetic classification of Alzheimer disease(s) (AD) is presented. We describe a potential metabolic process in individuals who inherit apolipoprotein E-ε(lunate)4 (APOE4, gene; apoE4, protein) alleles, leading to increased risk and earlier age of onset of late-onset Alzheimer disease. Apolipoprotein E-ε(lunate)3 (apoE3) binds to tau protein, possibly slowing the initial rate of tau phosphorylation and self-assembly into paired helical filments (PHFs); apoE4 does not bind tau. Tau promotes microtubule assembly and stabilizes microtubules; hyperphosphorylated tau does not bind, thereby destabilizing microtubules. Hyperphosphorylated tau may self-assemble into PHFs. Over time a bias toward destabilization of microtubules and the formation of neurofibrillary tangles may occur in individuals who inherit APOE4 alleles, leading to a shorter functional neuronal life span. This hypothesis focuses attention on two important aspects of AD research design: (1) Although the inheritance of APOE4 is associated with increased risk and decreased age of onset, apoE4 does not directly cause the disease. Our data point to the absence of an important function of apoE3 or apoE2 in individuals who do not inherit these alleles as the genetically relevant metabolic factor. This has important implications for design of experiments directed toward understanding the relevant neuronal metabolism. (2) Should this hypothesis be proven and confirmed, targets for pharmaceutical therapy designed to mimic the metabolic function of apoE3 or apoE2 become a realistic preventive strategy.
AB - A genetic classification of Alzheimer disease(s) (AD) is presented. We describe a potential metabolic process in individuals who inherit apolipoprotein E-ε(lunate)4 (APOE4, gene; apoE4, protein) alleles, leading to increased risk and earlier age of onset of late-onset Alzheimer disease. Apolipoprotein E-ε(lunate)3 (apoE3) binds to tau protein, possibly slowing the initial rate of tau phosphorylation and self-assembly into paired helical filments (PHFs); apoE4 does not bind tau. Tau promotes microtubule assembly and stabilizes microtubules; hyperphosphorylated tau does not bind, thereby destabilizing microtubules. Hyperphosphorylated tau may self-assemble into PHFs. Over time a bias toward destabilization of microtubules and the formation of neurofibrillary tangles may occur in individuals who inherit APOE4 alleles, leading to a shorter functional neuronal life span. This hypothesis focuses attention on two important aspects of AD research design: (1) Although the inheritance of APOE4 is associated with increased risk and decreased age of onset, apoE4 does not directly cause the disease. Our data point to the absence of an important function of apoE3 or apoE2 in individuals who do not inherit these alleles as the genetically relevant metabolic factor. This has important implications for design of experiments directed toward understanding the relevant neuronal metabolism. (2) Should this hypothesis be proven and confirmed, targets for pharmaceutical therapy designed to mimic the metabolic function of apoE3 or apoE2 become a realistic preventive strategy.
UR - http://www.scopus.com/inward/record.url?scp=0028269666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028269666&partnerID=8YFLogxK
U2 - 10.1006/exnr.1994.1019
DO - 10.1006/exnr.1994.1019
M3 - Article
C2 - 8313935
AN - SCOPUS:0028269666
SN - 0014-4886
VL - 125
SP - 163
EP - 171
JO - Neurodegeneration
JF - Neurodegeneration
IS - 2
ER -